The whole genome amplification market is anticipated to reach over USD 6.5 million by 2034, with sales projected to reach USD 2.9 million in 2024. The WGA industry is envisioned to register an 8.1% CAGR between 2024 and 2034, highlighting its sustained demand and potential impact on various research fields.
The demand for whole genome amplification is developing at a prompt pace due to the demand for genetic data collection in order to identify and map every gene in the human genome. The method of whole-cell genome amplification has gained attention in recent times, with rising awareness and initiatives to spread information about this technique.
It is estimated that such awareness and initiatives are anticipated to create lucrative market growth opportunities during the forecast period.
Several other aspects, such as rising government backing, an upsurge in the number of genome studies being conducted, and a reduction in whole-genome sequencing costs, are propelling the whole genome amplification market. Further, the increased applications of genomics in various fields are contributing to the growth of the whole genome amplification industry.
The budding research in molecular diagnostics and genomics, as well as the growing adoption of customized medicine, are also key propellers of the whole genome amplification and genomics industries.
The entire genome amplification sector is poised for significant growth in the coming decade, helmed by a combination of factors such as increased awareness, government support, and growing adoption of genomics in numerous sectors.
The demand for whole genome amplification (WGA) is a complex process in the medical sector that involves enzymatically replicating a small amount of genomic DNA, typically in nanograms, through a polymerase chain reaction, resulting in a larger amount of amplified products, typically in micrograms.
The demand for WGA is paramount in scientific fields as the procedure increases the number of DNA specimens available for study, especially when working with conserved specimens, making the WGA easier to study organisms' genes in more splendid detail.
Whole-genome amplification is an essential technique in genomics and molecular biology, used in cancer research to identify genetic mutations contributing to tumor development and in forensic science to identify small DNA samples found at crime scenes. The ability to increase the quantity of DNA specimens available for research has made it an essential tool in various scientific fields.
| Attributes | Description |
|---|---|
| Estimated Whole Genome Amplification Industry Valuation For 2024 | USD 2.9 million |
| Projected Whole Genome Amplification Industry Valuation By 2034 | USD 6.5 million |
| Value-based CAGR (2024 to 2034) | 8.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Geriatric Patient Pool Caters to WGA Procedures for Chronic Diseases
As the global population ages, the incidence of chronic diseases such as cancer and arthritis is on the rise. To address such healthcare challenges, whole genome amplification is being popularly explored as a promising solution.
The innovative medical technology allows healthcare researchers to amplify the entire genome of a single cell, providing a wealth of data that can help identify genetic mutations and biomarkers associated with various diseases.
By enabling more accurate and comprehensive analysis of the human genome, whole genome amplification is anticipated to play a binding position in advancing personalized medicine and improving outcomes for patients with chronic diseases.
Integration of AI and Other Technologies in Forensic Science
The integration of artificial intelligence and machine learning technologies has significantly impacted genome research, particularly in optimizing CRISPR designs for precise gene editing. Such endeavors have enabled researchers to analyze large genomic datasets more efficiently and accurately, predicting off-target effects more accurately, leading to faster experimentation and reduced time and resources needed for genome editing research.
The usage of AI and machine learning in genome amplification is on the rise, with the development of novel technologies anticipated to develop demand for forensic technological science. The advanced technologies enable researchers to analyze large genomic datasets more effectively, allowing the patrons to understand complex patterns.
Leading to more accurate and efficient forensic technologies for solving complex cases. The integration of AI and machine learning in genome research is envisioned to compel innovation and advancement in the forensic science field.
Research and Development of Medical Sciences Presents Lucrative Opportunities
The growing patient pool with a heap of chronic diseases like arthritis, heart disorders, and cancer is anticipated to compel transition in the whole genome amplification industry. Additionally, augmented funding for clinical trials is envisioned to provide novel growth opportunities in the medical technologies sector over the estimated timeline.
A research study by NIH researchers on whole genome amplification from a single cell found it useful for diagnosing genetic diseases, forensics, and accurately analyzing old DNA samples. Such a study is foreseen to boost the significance of whole genome amplification and result in industry development in the forthcoming decade.
According to the NCBI, the use of polymerase chain reaction to duplicate physiologically significant genomes has led to an increase in whole genome amplification in recent years. Applications include genotyping, clinical sample immortalization, bioterrorism, microbial diversity, and diagnosis of embryonic diseases.
The maturation presents novel prospects for molecular biology and indicates that the genome amplification industry is desired to increase remarkably over the subsequent years.
The global demand for WGA has historically developed at a CAGR of 7.8%. However, the demand for whole genome amplification has advanced at a trifling pace, displaying a CAGR of 8.1% from 2024 to 2034.
The whole genome amplification market outlook considers supply chain disruptions due to global geopolitical issues, trade tariffs, restrictions, production loss, and availability of alternatives. It also considers the impact of inflation on food at home and food service, and the correlation between past economic downturns and current market trends to predict the impact on the gene amplification technologies sector.
The demand for WGA kits is envisioned to boost due to the increasing demand for DNA kits and reagents in molecular diagnostics and genomics research, as well as the global pandemic, which has bolstered the demand.
The whole cell genome amplification sector is anticipated to rise significantly over the next several years because of measures to disseminate knowledge and raise awareness. Such endeavors are envisioned to open up profitable market prospects.
Global consumption is estimated to improve because of innovation in enhancing the dependability of whole-cell genome amplification kits. The whole-cell genome amplification industry is developing as a result of firms making influential investments in the creation of novel products to satisfy consumer demand.
Principal Consultant
The following section depicts the development of whole genome amplification sectors in different regions. According to recent findings, the demand for gene amplification technologies from the United States, China, and India is highlighting the prominent progress in the forthcoming decade. The demand from Russia and Germany is establishing their consumer base in the global market.
| Countries | CAGR from 2024 to 2034 |
|---|---|
| United States | 7.4% |
| Germany | 9.2% |
| Russia | 8.2% |
| China | 8.9% |
| India | 8.7% |
The United States significantly contributes to the global genome amplification market's development of medical technologies and DNA science through revenue generation, active research participation, and notable businesses, fostering regional market growth.
The WGA sector in the United States is predicted to report a CAGR of 7.4% between 2024 and 2034, helmed by the presence of advanced healthcare facilities, increased genetic testing, and ongoing research activities.
The United States government's increasing investment in medical research and infrastructure is envisioned to boost the growth of the gene amplification technologies market in the country, paving the way for significant genomics advancements in the healthcare industry.
The demand for whole genome amplification is foreseen to witness progress in China during the projected period. The industry growth is attributed to the increasing prevalence of various diseases and the growing need for genomic research in the country.
China, being one of the rigid medical sectors globally, is projected to witness a significant surge in the demand for medical technologies, with a CAGR of 8.9% from 2024 to 2034. The favorable initiatives implemented by the government in China to establish advanced healthcare facilities are anticipated to drive the demand for whole genome amplification in the region.
India's healthcare infrastructure has been bolstered by the emergence of large biotechnological businesses, increased research activity, and efforts to support genomics initiatives.
The Indian demand for whole genome amplification is envisioned to report a CAGR of 8.7% from 2024 to 2034. Notably, leading players in the market are collaborating with biopharma developers to aid in the product development process.
The Indian government's funding structure is predicted to boost the whole genome amplification market, driven by rising demand for next-generation sequencing and genomics' importance in personalized treatment. The rising cancer incidence is also anticipated to propel the adoption of whole genome amplification in the genomics market.
Details on the peak segments of the sector are provided in the subsequent section. Single cell WGA kit is estimated to have a 49.1% revenue share of the industry, depending on the product type. Furthermore, in 2024, agriculture and veterinary applications are projected to account for 73.1% of the WGA market.
| Product | Single Cell WGA Kit |
|---|---|
| Value Share (2024) | 49.1% |
The global revenue share of single-cell WGA kits is anticipated to account for 49.1% in 2024 due to the rising demand from multiple healthcare establishments. Through 2034, single-cell whole-genome sequencing (WGA) is anticipated to propel market growth by launching new product categories and deepening our knowledge of genetic variation in intricate biological systems.
Using RT-PCR and specialist WGA PCR kits, WGA is actively employed in the screening process for neurological and developmental genetic illnesses. It plays a vital role in opening up new applications for the whole genome amplification industry.
The single-cell WGA method, which uses next-generation sequencing technology to analyze sequence data from a single cell, is a potent tool for comprehending genetics and propelling the use of whole genome amplification.
| Application | Agriculture and Veterinary |
|---|---|
| Value Share (2024) | 73.1% |
The agriculture and veterinary sectors are expected to maintain their market share leadership, accounting for 73.1% of revenue share in 2024, according to the WGA application. Despite advancements in genetic and genomic treatments, the integration of genomic services remains a crucial topic in many nations.
The main goal is to restructure professional roles and duties, requiring effective coordination among professionals providing unique quality pesticides and grain reframing. This involves developing new connections, improving knowledge sharing, and improving genomic data, including crucial service details.
Major genetic centers collaborate with local genomic pet clinics to increase demand for DNA modification in animal husbandry. This collaboration can improve animal health and welfare, contribute to the growth of agriculture and veterinary sectors, and enhance general animal welfare.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The whole genome amplification market is poised to experience notable growth in the near future, owing to several factors. One of the main aspects of the dynamic growth is the increasing number of collaborations and partnerships between operating firms, leading to heightened market competition.
The demand for whole genome amplification is anticipated to develop due to the proliferation of product portfolios and strategic initiatives such as mergers and acquisitions, licensing, and partnerships. Such major mergers and acquisitions have further fuelled the growth of the market, contributing to the comprehensive expansion.
For instance
As per product type, the industry has been segmented into single-cell WGA kits, complete WGA kits, WGA re-amplification kits, WGA and chip DNA kits, and others.
The segment is branched into applications for drug discovery and development, disease diagnosis, agriculture, veterinary research, forensics, and others.
Pharma and biotech companies, hospitals and clinics, contract research organizations, research and academic institutes, and others mainly utilize the sector.
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
The global industry is estimated at a value of USD 2.9 million in 2024.
From 2019 to 2023, the sales of whole genome amplification are estimated to register a CAGR of 7.8%.
The sector will be valued at USD 6.5 million by 2034.
The industry is anticipated to register a CAGR of 8.1% from 2024 to 2034.
The United States is anticipated to hold a CAGR of 7.4% from 2024 to 2034.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 7.1. Single Cell WGA Kit 7.2. Complete WGA Kit 7.3. WGA Re-Amplification Kit 7.4. WGA & Chip DNA Kit 7.5. Others 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 8.1. Drug Discovery & Development 8.2. Disease Diagnosis 8.3. Agriculture & Veterinary 8.4. Research 8.5. Forensics 8.6. Others 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 9.1. Pharma & Biotech Companies 9.2. Hospitals & Clinics 9.3. Contract Research 9.4. Research & Academic Institutes 9.5. Others 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. South Asia 10.5. East Asia 10.6. Eastern Europe 10.7. Middle East & Africa 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. South Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Sales Forecast 2024 to 2034 by Product Type, Application, and End User for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. GE Healthcare 20.2. Sygnis AG 20.3. Illumina, Inc. 20.4. Merck KGaA 20.5. Thermo Fisher Scientific Inc. 20.6. Eurofins Scientific 20.7. Agilent Technologies, Inc. 20.8. Oxford Nanopore Technologies 20.9. F. Hoffmann-La Roche Ltd 20.10. Bio-Rad Laboratories, Inc.
Explore Healthcare Insights
View Reports
Whole Genome Amplification Market
